Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes Drug
Journal of the American Chemical Society · 2025
DOI: 10.1021/jacs.4c16743 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2025. Verfasst von Alexander I P Taylor und 9 weiteren Autor:innen. Beteiligte Einrichtung: Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, LS2 9…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Islet Amyloid Polypeptide, Canagliflozin, Amyloid. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Engineering and Physical Sciences Research Council, Royal Society.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, LS2 9JT Leeds, U.K.
- Astbury Centre for Structural Molecular Biology, School of Chemistry, Faculty of Engineering and Physical Sciences, University of Leeds, LS2 9JT Leeds, U.K.
ORCID-Profile: Alexander I P Taylor, Pijush Chakraborty, Richard Foster, Sheena E Radford
Förderung
- Wellcome Trust
- Engineering and Physical Sciences Research Council
- Royal Society
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
Zitieren
APA
Taylor, A. I. P., Xu, Y., Wilkinson, M., Chakraborty, P., Brinkworth, A., Willis, L. F., Zhuravleva, A., Ranson, N. A., Foster, R., & Radford, S. E. (2025). Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes Drug. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.4c16743
Vancouver
Taylor AIP, Xu Y, Wilkinson M, Chakraborty P, Brinkworth A, Willis LF, et al. Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes Drug. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.4c16743
BibTeX
@article{Taylor2025,
author = {Taylor, Alexander I P and Xu, Yong and Wilkinson, Martin and Chakraborty, Pijush and Brinkworth, Alice and Willis, Leon F and Zhuravleva, Anastasia and Ranson, Neil A and Foster, Richard and Radford, Sheena E},
title = {Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes Drug},
journal = {Journal of the American Chemical Society},
year = {2025},
doi = {10.1021/jacs.4c16743}
}
EUVIMED